CECILIA HANSFORD: Open Payments
NPI 1467416032 · PACE, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$768 in 48 payments from 6 companies in 2025. Trend: 2023 $363 · 2024 $411 · 2025 $768
Food & beverage: $768
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 25 | $394 |
| ABBVIE INC. | 18 | $265 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $40 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $29 |
| Astellas Pharma US Inc | 1 | $26 |
| Amgen Inc. | 1 | $15 |
Products named: Ozempic, QULIPTA, Rybelsus, TRINTELLIX, Kerendia, Veozah, EVENITY, VRAYLAR.
Industry payments across FL — which companies pay providers there.
